| 2008 |
CD63 is endocytosed via a clathrin-dependent pathway at the cell surface and is enriched on intraluminal vesicles of late endosomes/multivesicular bodies, from which it can be secreted as exosomes through fusion of endosomes with the plasma membrane. Evidence was also presented for a role of caveolae in CD63 endocytosis. |
Subcellular fractionation, live-cell imaging, electron microscopy, review of trafficking studies |
Experimental cell research |
High |
18930046
|
| 2021 |
CD63 traffics from the endoplasmic reticulum to late endosomes where it resides, distinct from CD9 which localizes predominantly at the plasma membrane. A PM-stabilized mutant CD63 is more abundantly released in EVs than wild-type CD63, indicating that in HeLa cells ectosomes (PM-derived) are more prominent than exosomes (endosome-derived). Proteomic comparison identified LAMP1 as likely specific to exosomes and BSG/SLC3A2 as likely ectosome-specific. |
Live intracellular tracking, comparative proteomics, pH neutralization experiments, mutant CD63 stabilized at plasma membrane |
Nature communications |
High |
34282141
|
| 2006 |
CD63 was identified as a direct cell-surface binding partner for TIMP-1 by yeast two-hybrid screening, confirmed by co-immunoprecipitation. CD63 forms a complex with TIMP-1 and integrin β1 on the cell surface. shRNA-mediated CD63 knockdown reduced TIMP-1 binding, TIMP-1/integrin β1 co-localization, integrin β1 activation, cell survival signaling, and apoptosis inhibition in 3D matrigel cultures. |
Yeast two-hybrid, co-immunoprecipitation, confocal microscopy, shRNA knockdown, 3D matrigel assay |
The EMBO journal |
High |
16917503
|
| 2000 |
In human endothelial cells, CD63 distributes predominantly to internal membranes of multivesicular-multilamellar late endosomes containing lysobisphosphatidic acid, and is also present in Weibel-Palade bodies. CD63 cycles between late endosomes and Weibel-Palade bodies; treatment with U18666A (mimicking Niemann-Pick C) blocked this cycling and caused accumulation in late endosomes. |
Immunofluorescence, subcellular fractionation, drug treatment (U18666A), electron microscopy |
Molecular biology of the cell |
High |
10793155
|
| 1997 |
CD63 and CD81 form specific complexes with integrin α3β1 that also contain a phosphatidylinositol 4-kinase (PI 4-K, consistent with type II, ~55 kDa). PI 4-K co-purified with CD63 independently of α3β1. These complexes localize to focal complexes at the cell periphery rather than focal adhesions, providing a signaling pathway distinct from conventional integrin/FAK signaling. |
Enzymatic assays (PI 4-K activity), co-immunoprecipitation, immunochemical assays, subcellular localization |
The Journal of biological chemistry |
High |
9006891
|
| 1995 |
CD63 specifically associates with VLA-3 (α3β1) and VLA-6 (α6β1) integrins but not α2β1 or α5β1, as demonstrated by co-immunoprecipitation from Brij 96 lysates. The cytoplasmic domain of α3 was neither required nor sufficient for CD63 association, indicating interaction elsewhere in the complex. |
Monoclonal antibody screening, co-immunoprecipitation, immunofluorescence colocalization, large-scale purification and N-terminal sequencing |
The Journal of biological chemistry |
High |
7629079
|
| 1993 |
CD63 (granulophysin) is a component of platelet dense granules and lysosomes; it is deficient in Hermansky-Pudlak syndrome platelets. Anti-CD63 antibodies cross-block anti-granulophysin antibodies, and N-terminal sequencing confirmed identity between granulophysin, CD63, ME491, and pltgp40. FACS revealed biphasic CD63 surface expression after thrombin stimulation in control but not HPS platelets, indicating exocytosis-coupled surface exposure. |
Immunofluorescence, immunoblotting, FACS, ELISA, N-terminal amino acid sequencing, sequential immunodepletion |
The Journal of clinical investigation |
High |
7682577
|
| 1993 |
CD63 is a component of Weibel-Palade bodies in human endothelial cells, co-localizing with von Willebrand factor and P-selectin. CD63 biosynthesis and glycosylation pattern in endothelial cells were confirmed by Western blotting of subcellular fractions enriched in Weibel-Palade bodies. |
Monoclonal antibody generation, immunofluorescence, Western blotting of subcellular fractions, immunopurification |
Blood |
High |
8353283
|
| 2003 |
CD63 enhances internalization of the H,K-ATPase β-subunit. CD63 co-localizes with and co-precipitates the β-subunit in parietal cells and COS-7 cells. Co-expression with CD63 redistributes the β-subunit from the cell surface to CD63+ intracellular compartments via enhanced endocytosis. This depends on CD63's ability to interact with adaptor protein complexes AP-2 and AP-3. |
Co-immunoprecipitation, immunofluorescence, biochemical endocytosis assays, CD63 mutant analysis, COS-7 overexpression |
Proceedings of the National Academy of Sciences of the United States of America |
High |
14660791
|
| 2017 |
CD63 is required for efficient exosomal packaging of EBV oncoprotein LMP1 into MVB-derived vesicles. CRISPR/Cas9 knockout of CD63 reduced LMP1-induced particle secretion and severely impaired LMP1 packaging. CD63 KO was associated with disrupted perinuclear localization of LMP1 and increased noncanonical NF-κB and MAPK/ERK activation, while LMP1 trafficking to lipid rafts and canonical NF-κB/PI3K-Akt pathways were unaffected. |
CRISPR/Cas9 knockout, nanoparticle tracking analysis, gradient purification, immunoisolation of CD63+ exosomes, western blotting |
Journal of virology |
High |
27974566
|
| 2018 |
CD63 regulates the intersection of endosomal and autophagic pathways. CD63-dependent vesicle protein secretion opposes LMP1-mediated intracellular signaling including mTOR-associated proteins. CD63 KO resulted in mTOR activation coincident with development of serum-dependent autophagic vacuoles that are acidified in the presence of high LMP1 levels. Disruption of autolysosomal processes increased LMP1 secretion and dampened signal transduction. |
CD63 knockout cells, mTOR pathway analysis, autophagy assays, acidification measurements, vesicle secretion quantification |
Journal of virology |
Medium |
29212935
|
| 2021 |
CD63 expression is regulated by the IRE-IRP system via a canonical IRE in the 5' UTR of CD63 mRNA. Iron loading increases CD63 expression and secretion of CD63+ EVs containing ferritin-H and ferritin-L. Under iron loading, intracellular ferritin is transferred via NCOA4 to CD63+ EVs for secretion. |
IRE identification in CD63 5'UTR, iron loading experiments, EV isolation, western blotting for ferritin subunits, NCOA4 functional studies |
Blood |
High |
34265052
|
| 2014 |
RPN2 (ribophorin II, part of N-oligosaccharyltransferase complex) mediates N-glycosylation of CD63. RPN2 knockdown reduces CD63 glycosylation and deregulates its localization. CD63 silencing displaced MDR1 from the cell surface, reducing chemoresistance and invasion ability of breast cancer cells. |
RPN2 knockdown, glycosylation analysis, subcellular localization studies, invasion assays, MDR1 localization by immunofluorescence |
Molecular cancer |
Medium |
24884960
|
| 2016 |
CD63 forms a complex with syntenin-1 and ALIX in early CD63-positive endosomes after HPV internalization. This CD63-syntenin-1-ALIX complex controls delivery of internalised HPV particles to multivesicular endosomes; depletion of CD63 or syntenin-1 markedly suppressed infectivity of HPV types 16, 18 and 31 and impaired capsid disassembly. |
Co-immunoprecipitation, electron microscopy, immunofluorescence, shRNA depletion, infectivity assays |
Scientific reports |
High |
27578500
|
| 2017 |
A genome-wide haploid genetic screen identified CD63 as a host factor required for Lujo virus (LUJV) GP-mediated infection. CD63 stimulates pH-activated LUJV GP-mediated membrane fusion (distinct from its role as a cell-surface receptor). |
Genome-wide haploid genetic screen, recombinant VSV-LUJV infection assay, functional complementation |
Cell host & microbe |
High |
29120745
|
| 1996 |
CD63 associates with CD11/CD18 (Mac-1) and with tyrosine kinase activity (predominantly Src family kinases Lyn and Hck) in neutrophils. CD63 antibody cross-linking triggers a transient activation signal requiring extracellular calcium, upregulates CD11/CD18, and enhances neutrophil adhesion. |
Co-immunoprecipitation, protein kinase activity assays, flow cytometry, adhesion assays, calcium depletion experiments |
Journal of immunology |
Medium |
8871662
|
| 2004 |
CD63 in immature dendritic cells is internalized via the endocytic pathway through early endosomes, lysosomes, and MHC class II-enriched compartments (MIICs) within one hour of stimulation. CD63 is internalized during Saccharomyces cerevisiae phagocytosis and associates with dectin-1. CD63 was found to associate with integrins CD11b and CD18 by immunoprecipitation. CD63 antibodies enhanced DC migration and decreased surface expression of CD29, CD11b, CD18, and α5 integrins. |
Confocal immunofluorescence, flow cytometry, immunoprecipitation, phagocytosis assays, migration assays |
Blood |
Medium |
15130945
|
| 2008 |
CD63 is involved in granule targeting of neutrophil elastase (NE). CD63 associates with proNE upon co-expression, requiring intact large extracellular loop of CD63. CD63 depletion in HL-60 cells reduced NE processing (proNE to mature NE), reduced constitutive secretion, and caused lack of morphologically normal granules with absence of proNE/NE. CD63 thus participates in ER/Golgi export, cellular retention, and granule targeting of proNE. |
Co-immunoprecipitation (COS cells), RNAi in HL-60 cells, CD63 mutant expression, electron microscopy, secretion assays |
Blood |
High |
18669870
|
| 2013 |
CD63 is required for efficient FcεRI-mediated mast cell degranulation. CD63-deficient mast cells showed significant decrease in FcεRI-mediated β-hexosaminidase and TNF-α release, but normal PMA/ionomycin-induced degranulation, IL-6 secretion, and leukotriene C4 production. CD63-deficient mice showed attenuated cutaneous anaphylactic reactions upon local mast cell reconstitution. No ultrastructural differences in granule morphology or FcεRI-induced global tyrosine phosphorylation/Akt phosphorylation were observed. |
CD63 knockout mouse model, bone marrow-derived mast cell development, β-hexosaminidase release assay, passive cutaneous anaphylaxis, Kit(w/w-v) reconstitution |
Journal of immunology |
High |
23945142
|
| 2005 |
Anti-CD63 antibodies inhibit FcεRI-mediated mast cell degranulation but not leukotriene synthesis. This inhibition correlates with CD63-mediated inhibition of mast cell adhesion to fibronectin and vitronectin. Anti-CD63 impairs the Gab2-PI3K pathway essential for both degranulation and adhesion, without affecting global tyrosine phosphorylation or calcium mobilization. Anti-CD63 also inhibited FcεRI-mediated allergic reactions in vivo. |
Monoclonal antibody functional assays, adhesion assays, PI3K pathway analysis, calcium mobilization, in vivo allergy model |
The Journal of experimental medicine |
High |
15684326
|
| 2005 |
Upon platelet activation and exocytosis, CD63 relocates from dense granule/lysosome membranes to the plasma membrane where it associates with αIIbβ3-CD9 complex and the actin cytoskeleton in an αIIbβ3-dependent manner. Anti-CD63 antibody (D545) inhibited platelet spreading, F-actin reorganization, vinculin redistribution, tyrosine phosphorylation, and FAK phosphorylation on immobilized fibrinogen. CD63 co-immunoprecipitated with a PI 4-kinase type II activity regardless of activation state. |
Immunofluorescence, confocal imaging, co-immunoprecipitation, lipid kinase assays, flow cytometry |
Thrombosis and haemostasis |
Medium |
15711748
|
| 2008 |
CD63 deficiency in mice results in altered water balance: increased urinary flow, water intake, reduced urine osmolality, and abnormal intracellular lamellar inclusions in principal cells of the collecting duct. Despite CD63 abundance in late endosomes/lysosomes, loss of CD63 does not cause obvious endosomal/lysosomal abnormalities, suggesting functional compensation by other tetraspanins in most tissues. |
CD63 knockout mouse generation and analysis, histology, electron microscopy, water balance measurements, immune cell profiling |
Molecular and cellular biology |
High |
19075008
|
| 2008 |
CD63 associates with receptor-linked tyrosine phosphatase alpha (RPTPα) and c-Src in renal cortex and transfected 293T cells. CD63 expression stimulates c-Src activity (increased pY416, decreased pY527). The CD63-RPTPα-c-Src complex enhances c-Src-induced inhibition of ROMK1 potassium channels and increases ROMK1 tyrosine phosphorylation. |
Co-immunoprecipitation (native tissue and transfected cells), two-electrode voltage clamp in Xenopus oocytes, phosphorylation analysis, herbimycin A inhibition |
The Journal of biological chemistry |
High |
18211905
|
| 2016 |
CD63 interacts with human organic cation transporter 2 (hOCT2) as demonstrated by split-ubiquitin yeast 2-hybrid, pull-down, TIRF microscopy, FRET, and biotinylation assays. CD63 overexpression affects hOCT2 localization in HEK293 cells, and CD63-KO mice show impaired insertion of the mouse OCT2 ortholog into the proper basolateral membrane domain. CD63 and hOCT2 co-localize with Rab4, implicating CD63 in recycling from sorting endosomes to the basolateral membrane in polarized epithelia. |
Split-ubiquitin yeast 2-hybrid, pull-down, TIRF microscopy, FRET, biotinylation assay, CD63 KO mouse analysis, MDCK polarized cell studies |
FASEB journal |
High |
28031320
|
| 2006 |
CD63 recruitment to Cryptococcus neoformans-containing phagosomes (but not polystyrene bead phagosomes) requires phagosomal acidification and occurs independently of MHC class II and LAMP-1. This selective recruitment was demonstrated by live-cell imaging with mRFP-tagged CD63 in primary bone marrow-derived macrophages. |
Live-cell imaging with fluorescent-tagged CD63, acidification inhibitors, MyD88-deficient macrophages, primary bone marrow-derived cultures |
Proceedings of the National Academy of Sciences of the United States of America |
High |
17043215
|
| 2011 |
CD63 knockdown in EBV-transformed B cells (LCL) increased CD4+ T cell recognition of EBV antigens. This was not due to enhanced antigen processing or changes in MHC II expression. Exosome production significantly increased following CD63 knockdown, suggesting that CD63 negatively regulates exosome secretion and thereby MHC II-dependent T cell stimulation. |
shRNA knockdown, CD4+ T cell activation assays, exosome purification and quantification, MHC II expression analysis |
European journal of immunology |
Medium |
21660937
|
| 2010 |
TIMP-1 signaling via CD63 and integrin β1 mediates anoikis resistance in melanoma cells through PI3-K signaling independently of Akt phosphorylation. Differential association of the TIMP1-CD63-β1-integrin complex was observed along melanoma progression steps, demonstrated by co-immunoprecipitation. |
Co-immunoprecipitation, flow cytometry, PI3-K inhibitors (Wortmannin, LY294002), anchorage impediment model |
Molecular cancer |
Medium |
23522389
|
| 2015 |
TIMP-1 induces neutrophilia and granulopoiesis through CD63 signaling. The CD63-binding domain of TIMP-1 (distinct from its protease-inhibitory domain) was necessary and sufficient to augment granulopoiesis. Ablation of CD63 abolished both TIMP-1-induced neutrophilia and enhanced granulopoiesis in the bone marrow. |
TIMP-1 domain variants, CD63 knockout mice, BrdU pulse-labeling, bone marrow progenitor analysis, gene expression profiling |
Haematologica |
High |
26001794
|
| 2014 |
TIMP-1 binding to CD63 activates β1 integrin-mediated signaling through Akt and FAK phosphorylation, enhancing focal adhesion formation, cytoskeletal reorganization, and migration of human neural stem cells. shRNA ablation of CD63 attenuated TIMP-1-induced migration and spreading; blocking β1 integrin or PI3K also blocked migration. |
shRNA knockdown, microarray/proteomics, migration/adhesion assays, Akt/FAK phosphorylation analysis, antibody blocking |
The Biochemical journal |
Medium |
24635319
|
| 2019 |
TIMP-1/CD63/ITGB1/FAK signaling axis drives hypermotility in Toxoplasma gondii-infected dendritic cells. shRNA silencing of TIMP-1, CD63, or ITGB1 inhibited DC hypermotility; FAK inhibition (and inhibitors of SRC and PI3K) also abrogated hypermotility. This signaling cascade is hijacked by T. gondii for systemic dissemination. |
shRNA knockdown, antibody blockade, migration assays, kinase inhibitors |
Journal of cell science |
Medium |
30635444
|
| 2008 |
CD63 is required for HIV-1 replication in macrophages and cell lines. CD63-specific siRNA inhibited HIV replication in macrophages (>90% knockdown) and in U373-MAGI cells, suggesting roles in both early infection events and later post-integration replication steps. |
siRNA knockdown, HIV replication assay, macrophage and cell line models |
Virology |
Medium |
18682304
|
| 2014 |
CD63 plays a dual role in HIV-1 replication: supports Env-mediated (CD4/CCR5-dependent) entry or fusion (VSV/MLV pseudotype entry unaffected by CD63 silencing) and a post-integration step. CD63 co-localizes and co-immunoprecipitates with CD4 in macrophages, and CD63 silencing reduced expression of early HIV protein Tat and interaction with Gag, as well as late protein p24. |
siRNA knockdown, pseudotyped virus infectivity assays, co-immunoprecipitation, confocal microscopy, primary CD4+ T cells and dendritic cells |
Virology journal |
Medium |
24507450
|
| 2010 |
Ameloblastin binds CD63 and promotes CD63 binding to integrin β1. The CD63-integrin β1 interaction induces Src kinase inactivation via CD63 binding to Src. This mechanism promotes osteogenic differentiation, and anti-CD63 antibody or constitutively active Src reversed these effects. |
Co-immunoprecipitation, anti-CD63 antibody blockade, constitutively active Src overexpression, osteogenic differentiation assays |
Molecular and cellular biology |
Medium |
21149578
|
| 2011 |
CD63 mediates downregulation of CXCR4 in activated B cells by recruiting CXCR4 to late endosomes. BCL6 was found on the chromatin of the CD63 gene in resting B cells (functioning as a transcriptional repressor). siRNA knockdown of CD63 mRNA in Bcl6-deficient B cells upregulated CXCR4 expression, confirming CD63-dependent CXCR4 endosomal recruitment. |
siRNA knockdown, flow cytometry, chromatin immunoprecipitation (Bcl6 on CD63 gene), Bcl6 inhibitor experiments |
Journal of immunology |
Medium |
21270405
|
| 2021 |
CD63 is required to sustain TGFβ signaling in hematopoietic stem cells through its interaction with TGFβ receptors I and II. CD63-deficient HSCs exhibit impaired quiescence and long-term repopulating capacity. CD63-high HSCs are more quiescent with greater self-renewal and myeloid differentiation than CD63-low/negative HSCs. |
CD63 knockout mice, HSC transplantation, TGFβ signaling assays, co-immunoprecipitation (CD63 with TGFβRI/II), irradiation and 5-FU stress models |
Cell death and differentiation |
High |
34363017
|
| 2014 |
CD63 knockdown induces epithelial-like phenotype in melanoma cells with increased E-cadherin, downregulation of N-cadherin and Snail, and reduced β-catenin protein. β-catenin inhibitors mimicked this phenotype. CD63 overexpression reduces motility, invasiveness, protease activities, and tumor growth. CD63 regulates cell plasticity via PI3K/AKT-GSK3β-β-catenin pathway. |
siRNA knockdown, stable overexpression, β-catenin inhibitors, PI3K/AKT and GSK3β inhibitors, invasion assays, in vivo tumor xenograft |
International journal of cancer |
Medium |
25354204
|
| 1992 |
The CD63 gene (ME491) consists of eight exons spanning 4 kb. The 5'-flanking region lacks a TATA box but contains GC-rich sequences with SP1 and ETF binding sites, and a functional AP-1 binding site that positively regulates gene expression, as demonstrated by deletion mutant analysis. |
Genomic cloning, primer extension, reporter gene assays, 5'-deletion mutant analysis |
Biochemical and biophysical research communications |
Medium |
1599482
|
| 2007 |
Amelogenin interacts with CD63 via specific binding regions: the amelogenin PLSPILPELPLEAW region binds CD63 residues 165-205 (within the large extracellular loop EC2). This interaction mediates rapid endocytic uptake of amelogenin into CD63/LAMP1-positive vesicles in cells. |
In vitro binding assays, deletion/mutation mapping of binding regions, cell uptake experiments, confocal microscopy |
The Biochemical journal |
Medium |
17708745
|
| 2020 |
CD63 induces STAT3 activation to maintain the phenotype and function of CD63+ cancer-associated fibroblasts (CAFs). CD63+ CAFs secrete exosomes enriched in miR-22 (packaged via SFRS1) that confer tamoxifen resistance to breast cancer cells. |
Single-cell RNA sequencing, exosome isolation, SFRS1 functional studies, CD63-neutralizing antibody, STAT3 activation assays, xenograft models |
Advanced science |
Medium |
33173749
|
| 2002 |
CD63 mobilization from crystalloid granule membranes to the cell periphery and plasma membrane is associated with eosinophil mediator release (β-hexosaminidase, eosinophil peroxidase, RANTES). IFN-γ-induced CD63 mobilization preceded RANTES release, consistent with piecemeal degranulation. Both CD63 mobilization and mediator release were inhibited by dexamethasone and the tyrosine kinase inhibitor genistein. |
Confocal immunofluorescence, flow cytometry, secretion assays, pharmacological inhibition |
Blood |
Medium |
12010805
|
| 2020 |
CD63 negatively regulates hepatocellular carcinoma by suppressing IL-6/IL-27-induced STAT3 activation. CD63 overexpression inhibited HCC cell proliferation and migration, while knockdown promoted these; STAT3 blockade impaired the promotive effects of CD63 knockdown. |
Overexpression, knockdown, RNA-sequencing, dual-luciferase reporter, STAT3 inhibition, xenograft model |
Journal of cellular and molecular medicine |
Medium |
33277798
|